1.Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor.
Daisuke KAJIWARA ; Hiroto KAMODA ; Tsukasa YONEMOTO ; Shintaro IWATA ; Takeshi ISHII ; Toshinori TSUKANISHI ; Seiji OHTORI ; Masashi YAMAZAKI ; Akihiko OKAWA
Asian Spine Journal 2016;10(3):553-557
A 43-year-old male patient with C5 giant cell tumor (GCT) underwent tumor resection and anterior bone fusion of C4-C6. The tumor recurred locally 9 months after surgery with the patient complaining of neck and shoulder pain similar to his preoperative symptoms. Denosumab was administered and his pain disappeared after a two-month administration, with a sclerotic rim formation seen at the tumor site on computed tomography. He has been followed for 18 months with no evidence of tumor recurrence. Complete resection is generally recommended, but is not easy for many patients with cervical GCT because of the existence of neurovascular structures. Some patients suffer from recurrence and treatment becomes more difficult. As such, denosumab may be an efficacious option for treatment of recurrent GCT of the cervical spine, although long-term follow-up is required to monitor for presence or absence of recurrence.
Adult
;
Cervical Vertebrae
;
Denosumab*
;
Female
;
Follow-Up Studies
;
Giant Cell Tumor of Bone
;
Giant Cell Tumors
;
Humans
;
Male
;
Neck
;
Recurrence
;
Shoulder Pain
;
Spine
2.Assessment of the Initial Diagnostic Accuracy of a Fragility Fracture of the Sacrum: A Study of 56 Patients
Ryo UMEDA ; Yasushi IIJIMA ; Nanako YAMAKAWA ; Toshiaki KOTANI ; Tsuyoshi SAKUMA ; Shunji KISHIDA ; Keisuke UENO ; Daisuke KAJIWARA ; Tsutomu AKAZAWA ; Yasuhiro SHIGA ; Shohei MINAMI ; Seiji OHTORI ; Koichi NAKAGAWA
Asian Spine Journal 2023;17(6):1066-1073
Methods:
Fifty-six patients (13 males and 43 females) with an average age of 80.2±9.2 years admitted to the hospital for FFS between 2006 and 2021 were analyzed retrospectively. The following patient data were collected using medical records: pain regions, a history of trauma, initial diagnoses, and rates of fracture detection using radiography, computed tomography (CT), and magnetic resonance imaging (MRI).
Results:
Forty-one patients presented with low back and/or buttock pain, nine presented with groin pain, and 17 presented with thigh or leg pain. There was no history of trauma in 18 patients (32%). At the initial visit, 27 patients (48%) were diagnosed with sacral or pelvic fragility fractures. In contrast, 29 patients (52%) were initially misdiagnosed with lumbar spine disease (23 patients), hip joint diseases (three patients), and buttock bruises (three patients). Fracture detection rates for FFS were 2% using radiography, 71% using CT, and 93% using MRI. FFS was diagnosed definitively using an MRI with a coronal short tau inversion recovery (STIR) sequence.
Conclusions
Some patients with FFS have leg pain with no history of trauma and are initially misdiagnosed as having lumbar spine disease, hip joint disease, or simple bruises. When these clinical symptoms are reported, we recommend considering FFS as one of the differential diagnoses and performing lumbar or pelvic MRIs, particularly coronal STIR images, to rule out FFS.